White paper
Decoding biosimilar strategies: Key US payer trends for 2025
-
Shaila Yoshida
-
Tasmina Hydery
Stay ahead in the rapidly evolving biosimilar landscape with this comprehensive report exploring key trends shaping the U.S. payer environment. Based on insights from 51 payer decision-makers representing over 271 million PBM lives, this report delves into the factors driving biosimilar adoption, payer strategies for coverage, and the challenges and opportunities in managing pharmacy benefit biosimilars. Learn how biosimilars are transforming healthcare by offering cost-effective alternatives and uncover how payers are navigating pricing dynamics, formulary placement, and utilization management tools.
Key highlights:
- Trends in payer strategies for biosimilar coverage and contracting
- Factors driving biosimilar adoption and addressing barriers to uptake
- The role of pricing dynamics, rebates, and policy changes in influencing coverage decisions
- Insights into innovative programs increasing biosimilar access and affordability
- Future outlook for biosimilars, including the adoption of ustekinumab biosimilars
Discover how payers are shaping the future of biosimilars and what it means for healthcare stakeholders.
Access the white paper
Pardot Form
Connect with our team
Our commitment to helping clients achieve market access plays a crucial role in patients’ access to affordable, diverse, and effective therapies so they can achieve their best potential health outcomes. Connect with our team of experts to discover how we can help support your goals.
